Skip to main content
SpringerLink
Log in

Clinical course and complications of ulcerative colitis and ulcerative proctitis

  • Chapter
Book cover Inflammatory Bowel Disease: From Bench to Bedside

  • 1300 Accesses

Summary

The nature of UC has changed dramatically over the past five decades. Although the presentation of the disease has remained the same, the impact of the introduction of therapies such as corticosteroids and the aminosalicylates has changed the clinical course of the disease. The course of treated UC offers patients and physicians a much more optimistic out-look than that documented in earlier studies. The advances in medical therapy have been complemented by refinement of surgical techniques, which have improved the quality of life and gained patient acceptance. The new millennium will bring further promise to patients and to those of us who care for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Whalen G. Cancer risk in ulcerative colitis: why are results in the literature so varied? Clin Gastroenterol 1980; 9: 469–76.

    Google Scholar 

  2. Sparberg M, Fennessy J, Kirsner JB. Ulcerative proctitis and mild ulcerative colitis: a study of 220 patients. Medicine (Bait) 1966; 45: 391–412.

    CAS  Google Scholar 

  3. Greenstein AJ, Sachar DB, Gibas A et al. Outcome of toxic dilatation in ulcerative and Crohn’s colitis. J Clin Gastroenterol 1985; 7: 137–44.

    Article  PubMed  CAS  Google Scholar 

  4. Edwards F, Truelove S. The course and prognosis of ulcerative colitis I. Short-term prognosis. Gut 1963; 4: 299–308.

    PubMed  CAS  Google Scholar 

  5. Ritchie JK, Powell-Tuck J, Lennard-Jones JE. Clinical outcome of the first ten years of ulcerative colitis and proctitis. Lancet 1978; 1: 1140–3.

    Article  PubMed  CAS  Google Scholar 

  6. Lennard-Jones J, Cooper G, Newell A, Wilson G, Avery jones F. Observations on idiopathic proctitis. Gut 1962; 3:201–6.

    PubMed  CAS  Google Scholar 

  7. Goligher JC, Hoffman DC, de Dombal FT. Surgical treatment of severe attacks of ulcerative colitis, with special reference to the advantages of early operation. Br Med J 1970; 4: 703–6.

    PubMed  CAS  Google Scholar 

  8. Jalan KN, Prescott RJ, Sircus W et al. An experience of ulcerative colitis. II. Short term outcome. Gastroenterology 1970;59: 589–97.

    PubMed  CAS  Google Scholar 

  9. Watts JM, De Dombal FT, Watkinson G, Goligher JC. Early course of ulcerative colitis. Gut 1966; 7: 16–31.

    PubMed  CAS  Google Scholar 

  10. Sinclair TS, Brunt PW, Mowat NA. Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology 1983; 85: 1–11.

    PubMed  CAS  Google Scholar 

  11. Bonnevie O, Binder V, Anthonisen P, Riis P. The prognosis of ulcerative colitis. Scand J Gastroenterol 1974; 9: 81–91.

    PubMed  CAS  Google Scholar 

  12. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990; 31: 329–33.

    PubMed  CAS  Google Scholar 

  13. Jones HW, Grogono J, Hoare AM. Surveillance in ulcerative colitis: burdens and benefit. Gut 1988; 29: 325–31.

    PubMed  CAS  Google Scholar 

  14. Stonnington CM, Phillips SF, Zinsmeister AR, Melton LJd. Prognosis of chronic ulcerative colitis in a community. Gut 1987;28:1261–6.

    PubMed  CAS  Google Scholar 

  15. Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991; 100: 350–8.

    PubMed  CAS  Google Scholar 

  16. Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991;26:1247–56.

    PubMed  CAS  Google Scholar 

  17. Loftus EV, Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gut 2000; 46: 336–43.

    Article  PubMed  Google Scholar 

  18. Truelove SC, Pena AS. Course and prognosis of Crohn’s disease. Gut 1976; 17: 192–201.

    PubMed  CAS  Google Scholar 

  19. Truelove S, Witts L. Cortisone in ulcerative colitis. Final report on atherapeutic trial. Br Med J 1955: 2: 1041–8.

    PubMed  CAS  Google Scholar 

  20. Misiewicz J, Lennard-Jones J, Connell A, Baron J, Jones F. Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis. Lancet 1965; 12: 185–8.

    Article  Google Scholar 

  21. Brostrom O. Prognosis in ulcerative colitis. Med Clin N Am 1990; 74: 201–18.

    PubMed  CAS  Google Scholar 

  22. Both H, Torp-Pedcrsen K, Kreiner S, Hcndriksen C, Binder V. Clinical appearance at diagnosis of ulcerative colitis and Crohn’s disease in a regional patient group. Scand J Gastro enterol 1983; 18:987–91.

    CAS  Google Scholar 

  23. Mayberry JF, Ballantyne KC, Hardcastle JD, Mangham C, Pye G. Epidemiological study of asymptomatic inflammatory bowel disease: the identification of cases during a screening programme for colorectal cancer. Gut 1989; 30:481–3.

    PubMed  CAS  Google Scholar 

  24. Schumacher G, Sandstedt B, Mollby R, Kollberg B. Clinical and histologic features differentiating non-relapsing colitis from first attacks of inflammatory bowel disease. Scand J Gastroenterol 1991; 26: 151–61.

    PubMed  CAS  Google Scholar 

  25. Surawicz CM. Diagnosing colitis. Biopsy is best [editorial]. Gastroenterology 1987; 92: 538–40.

    PubMed  CAS  Google Scholar 

  26. Powell-Tuck J, Bown RL, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978; 13:833–7.

    Article  PubMed  CAS  Google Scholar 

  27. Sutherland LR, Martin F, Greer S et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987;92: 1894–8.

    PubMed  CAS  Google Scholar 

  28. Farmer RG, Brown CH. Emerging concepts of proctosigmoiditis. Dis Colon Rectum 1972; 15: 142–6.

    Article  PubMed  CAS  Google Scholar 

  29. Myers A, Humphreys DM, Cox EV. A ten-year follow-up of haemorrhagic proctitis. Postgrad Med J 1976; 52: 224–8.

    PubMed  CAS  Google Scholar 

  30. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993; 38: 1137–6.

    Article  PubMed  CAS  Google Scholar 

  31. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis — based on results from a regional patient group from the county of Copenhagen. Gut 1985; 26: 158–63.

    PubMed  CAS  Google Scholar 

  32. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years [See comments]. Gastroenterology 1994; 107: 3–11.

    PubMed  CAS  Google Scholar 

  33. Mourn B, Vatn MH, Ekbom A et al. Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists [Published erratum appears in Digestion 1996; 57: 104]. Digestio 1995; 56:377–81.

    Google Scholar 

  34. Geboes K, Ectors N. Diagnosis of ulcerative colitis in endoscopic biopsies. Hepatogastroenterology 1989; 36:188–92.

    PubMed  CAS  Google Scholar 

  35. Bernstein CN, Shanahan F, Anton PA, Weinstein WM. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc 1995; 42:232–7.

    Article  PubMed  CAS  Google Scholar 

  36. Panaccione R, Sandborn WJ. The appendix in ulcerative colitis: a not so innocent bystander. Gastroenterology 1999;117:272–3.

    Article  PubMed  CAS  Google Scholar 

  37. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative proctitis in central Sweden 1965–1983. A population-based epidemiological study. Dig Dis Sci 1991; 36: 97–102.

    Article  PubMed  CAS  Google Scholar 

  38. Baron J, Connell A, Lennard-Jones J. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964; 1:89–92.

    PubMed  CAS  Google Scholar 

  39. Rutgeerts P, Vantrappen G, Geboes K. Endoscopy in inflammatory bowel disease. Scand J Gastroenterol 1989;170(Suppl.): 12–15.

    CAS  Google Scholar 

  40. Etherington IJ, Luesley DM, Shan MI, Dunn J, Hiller L, Jordan JA. Observer variability among colposcopists from the West Midlands region. Br J Obstet Gynaecol 1997; 104:1380–4.

    PubMed  CAS  Google Scholar 

  41. Pera A, Bellando P, Caldera D et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 1987; 92:181–5.

    PubMed  CAS  Google Scholar 

  42. Morson B. Ulcerative Colitis. London: Balliere Tindall & Cassell; 1968: 5.

    Google Scholar 

  43. Sandborn WJ, Loftus EV Jr, Ahlquist DA. Association of primary sclerosing cholangitis and colorectal cancer in patients with ulcerative colitis: is it true and does it matter? Gastroenterology 1998; 115: 236–7.

    Article  PubMed  CAS  Google Scholar 

  44. Spiliadis CA, Lennard-Jones JE. Ulcerative colitis with relative sparing of the rectum. Clinical features, histology, and prognosis. Dis Colon Rectum 1987; 30: 334–6.

    Article  PubMed  CAS  Google Scholar 

  45. Hodgson HJ. The natural history of treated ulcerative colitis [Editorial; comment]. Gastroenterology 1994; 107: 300–2.

    PubMed  CAS  Google Scholar 

  46. Ilnyckyj A, Shanahan F, Anton PA, Cheang M, Bernstein CN. Quantification of the placebo response in ulcerative colitis [See comments]. Gastroenterology 1997; 112: 1854–8.

    Article  PubMed  CAS  Google Scholar 

  47. Meyers S, Janowitz H. The ‘natural history’ of ulcerative colitis: an analysis of the placebo response. J Clin Gastroenterol 1989; 11:33–7.

    Article  PubMed  CAS  Google Scholar 

  48. Stonnington CM, Phillips SF, Melton LJd, Zinsmeister AR. Chronic ulcerative colitis: incidence and prevalence in a community. Gut 1987; 28: 402–9.

    PubMed  CAS  Google Scholar 

  49. Mourn B, Ekbom A, Vatn MH et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn’s disease. Results of a large, prospective population-based study in southeastern Norway, 1990–93. Scand J Gastroenterol 1997; 32:1005–12.

    Article  Google Scholar 

  50. Brostrom O, Monsen U, Nordenwall B, Sorstad J, Hellers G. Prognosis and mortality of ulcerative colitis in Stockholm County, 1955–1979. Scand J Gastroenterol 1987; 22:907–13.

    PubMed  CAS  Google Scholar 

  51. Mourn B, Vatn MH, Ekbom A et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of south-eastern Norway, 1990–93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996; 31: 362–6.

    Google Scholar 

  52. De Dombal FT, Watts JM, Watkinson G, Goligher JC. The early course and prognosis of ulcerative colitis. Proc R Soc Med 1965; 58: 711–13.

    PubMed  Google Scholar 

  53. Watts JM, De Dombal FT, Watkinson G, Goligher JC. Long-term prognosis of ulcerative colitis. Br Med J 1966;5501:1447–53.

    Google Scholar 

  54. Edwards F, Truelove S. The course and prognosis of ulcerative colitis II. Long-term prognosis. Gut 1963; 4:309–15.

    Google Scholar 

  55. Langholz E, Munkholm P, Davidsen M, Nielsen OH, Binder V. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996; 31: 260–6.

    PubMed  CAS  Google Scholar 

  56. Kangro HO, Chong SK, Hardiman A, Heath RB, Walker-Smith JA. A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology 1990; 98:549–53.

    PubMed  CAS  Google Scholar 

  57. Myszor M, Calam J. Seasonality of ulcerative colitis [Letter]. Lancet 1984; 2: 522–3.

    Article  PubMed  CAS  Google Scholar 

  58. Karamanolis DG, Delis KC, Papatheodoridis GV, Kalafatis E, Paspatis G, Xourgias VC. Seasonal variation in exacerbations of ulcerative colitis. Hepatogastroenterology 1997;44: 1334–8.

    PubMed  CAS  Google Scholar 

  59. Tysk C, Jarnerot G. Seasonal variation in exacerbations of ulcerative colitis. Scand J Gastroenterol 1993; 28: 95–6.

    PubMed  CAS  Google Scholar 

  60. Rampton DS, McNeil NI, Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut 1983; 24: 187–9.

    PubMed  CAS  Google Scholar 

  61. Weber P, Koch M, Heizmann WR, Scheurlen M, Jenss H, Hartmann F. Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol 1992; 14: 302–8.

    Article  PubMed  CAS  Google Scholar 

  62. Burke DA, Axon AT. Clostridium difficile, sulphasalazine, and ulcerative colitis. Postgrad Med J 1987; 63: 955–7.

    PubMed  CAS  Google Scholar 

  63. Gryboski JD. Clostridium difficile in inflammatory bowel disease relapse. J Pediatr Gastroenterol Nutr 1991; 13: 39–41.

    Article  PubMed  CAS  Google Scholar 

  64. Trnka YM, LaMont JT. Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology 1981; 80: 693–6.

    PubMed  CAS  Google Scholar 

  65. Meyers S, Mayer L, Bottone E, Desmond E, Janowitz HD. Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology 1981; 80:697–70.

    PubMed  CAS  Google Scholar 

  66. Greenfield C, Aguilar Ramirez JR, Pounder RE et al. Clostridium difficile and inflammatory bowel disease. Gut 1983; 24: 713–7.

    PubMed  CAS  Google Scholar 

  67. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31: 800–6.

    PubMed  CAS  Google Scholar 

  68. Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 1992; 103: 954–60.

    PubMed  CAS  Google Scholar 

  69. Persson PG, Bernell O, Leijonmarck CE, Farahmand BY, Hellers G, Ahlbom A. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 1996; 110: 1339–45.

    Article  PubMed  CAS  Google Scholar 

  70. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis [See comments]. Gastroenterology 1992; 103: 1444–51.

    PubMed  CAS  Google Scholar 

  71. Garrett JW, Drossman DA. Health status in inflammatory bowel disease. Biological and behavioral considerations. Gastroenterology 1990; 99: 90–6.

    PubMed  CAS  Google Scholar 

  72. Michener WM, Farmer RG, Mortimer EA. Long-term prognosis of ulcerative colitis with onset in childhood or adolescence. J Clin Gastroenterol 1979; 1: 301–5.

    Article  PubMed  CAS  Google Scholar 

  73. Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989; 34: 1379–86.

    Article  PubMed  CAS  Google Scholar 

  74. Verhoef MJ, Sutherland LR. Outpatient health care utilization of patients with inflammatory bowel disease. Dig Dis Sci 1990; 35: 1276–80.

    Article  PubMed  CAS  Google Scholar 

  75. Hjortswang H, Strom M, Aimer S. Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol 1998; 93: 2203–11.

    Article  PubMed  CAS  Google Scholar 

  76. Sullivan M, Ahlmen M, Archenholtz B, Svensson G. Measuring health in rheumatic disorders by means of a Swedish version of the sickness impact profile. Results from a population study. Scand J Rheumatol 1986; 15: 193–200.

    PubMed  CAS  Google Scholar 

  77. Farmer RG, Easley KA, Farmer JM. Quality of life assessment by patients with inflammatory bowel disease [See comments]. Cleve Clin J Med 1992; 59: 35–42.

    PubMed  CAS  Google Scholar 

  78. Wyke RJ, Edwards FC, Allan RN. Employment problems and prospects for patients with inflammatory bowel disease [Published erratum appears in Gut 1988; 1756]. Gut 1988;29: 1229–35.

    PubMed  CAS  Google Scholar 

  79. Burnham WR, Lennard-Jones JE, Brooke BN. Sexual problems among married ileostomists. Survey conducted by the Ileostomy Association of Great Britain and Ireland. Gut 1977; 18:673–7.

    PubMed  CAS  Google Scholar 

  80. Mclntyre PB, Pemberton JH, Wolff BG, Beart RW, Dozois RR. Comparing functional results one year and ten years after ileal pouch anal anastomosis for chronic ulcerative colitis. Dis Colon Rectum 1994; 37: 303–7.

    Article  Google Scholar 

  81. Kohler LW, Pemberton JH, Zinsmeister AR, Kelly KA. Quality of life after proctocolectomy. A comparison of Brooke ileostomy, Kock pouch, and ileal pouch anal anastomosis [See comments]. Gastroenterology 1991; 101: 679–84.

    PubMed  CAS  Google Scholar 

  82. McLeod RS, Churchill DN, Lock AM, Vanderburgh S, Cohen Z. Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology 1991;101: 1307–13.

    PubMed  CAS  Google Scholar 

  83. Provenzale D, Shearin M, Phillips-Bute BG et al. Health-related quality of life after ileoanal pull-through evaluation and assessment of new health status measures. Gastroenterology 1997; 113:7–14.

    Article  PubMed  CAS  Google Scholar 

  84. Carr N, Schofield PF. Inflammatory bowel disease in the older patient. Br J Surg 1982; 69: 223–5.

    Article  PubMed  CAS  Google Scholar 

  85. Zimmerman J, Gavish D, Rachmilewitz D. Early and late onset ulcerative colitis: distinct clinical features. J Clin Gastroenterol 1985; 7: 492–8.

    Article  PubMed  CAS  Google Scholar 

  86. Gupta S, Saverymuttu SH, Keshavarzian A, Hodgson HJ. Is the pattern of inflammatory bowel disease different in the elderly? Age Ageing 1985; 14: 366–70.

    Article  PubMed  CAS  Google Scholar 

  87. Earle E, Rowe RJ. Ulcerative disease of the large intestine in patients more than 50 years old. Dis Colon Rectum 1972;15: 33–40.

    Article  PubMed  CAS  Google Scholar 

  88. Brandt LJ, Boley SJ, Mitsudo S. Clinical characteristics and natural history of colitis in the elderly. Am J Gastroenterol 1982; 77: 382–6.

    PubMed  CAS  Google Scholar 

  89. Jalan KN, Prescott RJ, Sircus W et al. An experience of ulcerative colitis. 3. Long term outcome. Gastroenterology 1970; 59: 598–609.

    PubMed  CAS  Google Scholar 

  90. Fleischer DE, Grimm IS, Friedman LS. Inflammatory bowel disease in older patients. Med Clin N Am 1994; 78:1303–19.

    PubMed  CAS  Google Scholar 

  91. Jones HW, Hoare AM. Does ulcerative colitis behave differently in the elderly? Age Ageing 1988; 17: 410–4.

    Article  PubMed  CAS  Google Scholar 

  92. Edwards F, Truelove SC. The course and prognosis of ulcerative colitis III. Complications. Gut 1964; 5: 1–15.

    PubMed  CAS  Google Scholar 

  93. Jalan KN, Sircus W, Card WI et al. An experience of ulcerative colitis. I. Toxic dilation in 55 cases. Gastroenterology 1969; 57: 68–82.

    PubMed  CAS  Google Scholar 

  94. Marshak R. Toxic dilatation of the colon in the course of ulcerative colitis. Gastroenterology 1960; 38: 165.

    PubMed  CAS  Google Scholar 

  95. Grant CS, Dozois RR. Toxic megacolon: ultimate fate of patients after successful medical management. Am J Surg 1984; 147: 106–10.

    Article  PubMed  CAS  Google Scholar 

  96. De Dombal FT, Watts JM, Watkinson G, Goligher JC. Local complications of ulcerative colitis: stricture, pseudo-polyposis, and carcinoma of colon and rectum. Br Med J 1966; 5501: 1442–7.

    Article  Google Scholar 

  97. Goulston SJ, McGovern VJ. Nature of strictures in chronic ulcerative colitis. Gut 1969; 10: 952.

    PubMed  CAS  Google Scholar 

  98. Reiser JR, Waye JD, Janowitz HD, Harpaz N. Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol 1994; 89:119–22.

    PubMed  CAS  Google Scholar 

  99. Robert JH, Sachar DB, Aufses AH, Jr., Greenstein AJ. Management of severe hemorrhage in ulcerative colitis. Am J Surg 1990; 159: 550–5.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Calgary, Calgary, Alberta, Canada

    Remo Panaccione (Assistant Clinical Professor) & Lloyd R. Sutherland (Professor of Medicine)

Authors
  1. Remo Panaccione
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lloyd R. Sutherland
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cedars-Sinai IBD Center, Los Angeles, CA, USA

    Stephan R. Targan  & Loren C. Karp  & 

  2. Cork University Hospital, Cork, Ireland

    Fergus Shanahan

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Kluwer Academic Publishers

About this chapter

Cite this chapter

Panaccione, R., Sutherland, L.R. (2003). Clinical course and complications of ulcerative colitis and ulcerative proctitis. In: Targan, S.R., Shanahan, F., Karp, L.C. (eds) Inflammatory Bowel Disease: From Bench to Bedside. Springer, Boston, MA. https://doi.org/10.1007/0-387-25808-6_14

Download citation

  • DOI: https://doi.org/10.1007/0-387-25808-6_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-25807-2

  • Online ISBN: 978-0-387-25808-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation